Diane Weiser
Senior Vice President of Corporate Affairs
Replay available
Cytokinetics, Incorporated (CYTK) Q1 2026 Earnings Call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Stuart Kupfer
Senior Vice President & Chief Medical Officer
Sun Lee
Executive Vice President & Chief Financial Officer
Sadi Malik
Executive Vice President of Research & Development
Robert Blum
President & Chief Executive Officer
Andrew Callos
Executive Vice President & Chief Commercial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cytokinetics, Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.399 Hello, everyone. Thank you for standing by and welcome to the Cytokinetics Q1 2026 00:00:05.399 -- 00:00:10.707 earnings conference call. This call is being recorded and all participants 00:00:10.707 -- 00:00:16.135 are in a listen-only mode. There will be no question and answer session after the company's 00:00:16.135 -- 00:00:21.483 prepared remarks. I would now like to turn the call over to Diane Weiser, Cytokinetics 00:00:21.483 -- 00:00:23.967 Senior Vice President of Corporate Affairs. 00:00:23.967 -- 00:00:26.427 Please go ahead. 00:00:26.831 -- 00:00:29.950 Good afternoon and thanks for joining us on the call today. 00:00:29.950 -- 00:00:34.937 Robert Blum, President and Chief Executive Officer, will begin with an overview of the 00:00:34.937 -- 00:00:40.084 quarter and recent development. Andrew Callos, EVP and Chief Commercial 00:00:40.084 -- 00:00:44.129 Officer, will discuss the commercial launch of a mycorrhizal in the U.S. 00:00:44.129 -- 00:00:49.296 and readiness in Europe. Sadi Malik, EVP of R&D, will address the results 00:00:49.296 -- 00:00:54.563 from Acacia HCM. Stuart Kupfer, SVP and Chief Medical Officer, 00:00:54.563 -- 00:00:58.823 will provide updates related to our ongoing clinical development programs. 00:00:58.823 -- 00:01:03.849 Sun Lee, EVP and Chief Financial Officer, will provide a financial overview for 00:01:03.849 -- 00:01:08.776 the quarter. And finally, Robert will make closing remarks and review key milestones 00:01:08.776 -- 00:01:13.762 for the year ahead. As you can see on this slide, today's discussion will include forward-looking 00:01:13.762 -- 00:01:17.527 statements, which are subject to risks and uncertainties. 00:01:17.527 -- 00:01:21.612 Please refer to our SEC filings for a discuss...